Cases & Deals

  • Home
  • Practices
  • GRA Venture Fund participates in $25 million Series A financing round of Antios Therapeutics

Share

GRA Venture Fund participates in $25 million Series A financing round of Antios Therapeutics

November 2018

Client(s) GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC

Jones Day represented GRA Venture Fund in connection with its participation in the $25 million Series A financing round of Antios Therapeutics Inc., an Atlanta, Georgia-based biopharmaceutical company focused on the development of novel antiviral therapies for unmet medical needs.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.